Universal payment protection

Information

  • Patent Grant
  • 8447672
  • Patent Number
    8,447,672
  • Date Filed
    Thursday, April 7, 2011
    13 years ago
  • Date Issued
    Tuesday, May 21, 2013
    10 years ago
Abstract
A system for and method of providing payment protection upon the occurrence of trigger events. The system and method include an account, which may be associated with a credit card or other financial product. An accountholder may select trigger events and associated benefits. Upon the occurrence of a trigger event, the issuing entity will evaluate whether the accountholder is entitled to receive an associated benefit. Each benefit is intended to address at least one payment obligation. For example, an account may include payment protection in the form of automatic payment of minimum monthly credit card fees should the accountholder involuntarily become unemployed.
Description
FIELD OF THE INVENTION

The present invention generally relates to a system for and method of protecting entities with financial obligations. More particularly, the invention relates to a single account equipped with the ability to handle multiple financial obligations when certain trigger events occur.


DESCRIPTION OF RELATED ART

The present application incorporates by reference in their entireties the following patents and pending patent applications: U.S. Pat. No. 6,615,190 to Slater entitled “Sponsor-Funded Stored Value Card”, Pending U.S. patent application Ser. No. 10/268,763 to Slater entitled “Sponsor Funded Stored Value Card”, U.S. Pat. No. 6,615,189 to Phillips et al. entitled “Debit Purchasing Of Stored Value Card For Use By And/Or Delivery To Others”, U.S. patent application Ser. No. 10/681,148 to Ilijasic et al. entitled “System and Method for Insuring Financial Accounts”, and U.S. patent application Ser. No. 10/681,148 to Ilijasic et al. entitled “System And Method For Insuring Financial Accounts”.


SUMMARY OF THE INVENTION

According to an embodiment of the present invention, a system for and method of relieving an entity (e.g., an individual, a family, a business) from at least one payment obligation are disclosed. The embodiment includes receiving information relating to the entity and deciding whether to issue an account to the entity. The embodiment also includes issuing an account to the entity in response to the step of deciding. The embodiment further includes receiving data, the data being associated with at least one of the entity and the account. The data include: first information reflecting a trigger circumstance, the first information defining a potential future situation, and second information reflecting a benefit, the benefit being intended to address at least one payment obligation, where the payment obligation is not initially associated with the account. The embodiment further includes processing at least a portion of the data using at least one probabilistic computation, the probabilistic computation including at least one financial assessment associated with the trigger circumstance. The embodiment further includes receiving an indication that a trigger circumstance has occurred. The embodiment further includes comparing information in the indication to account information associated with the entity. The embodiment further includes determining, based on the account information associated with the entity and consistent with the data received from the entity, that the entity is entitled to the benefit. The embodiment further includes providing the benefit to the entity in accordance with the account information associated with the entity.


Various optional features of the above embodiment include the following. The embodiment may include a line of credit as the benefit. The line of credit may be intended to address any payment obligation. The line of credit may be restricted. The embodiment may include restricting who may receive funds from the line of credit. The line of credit may be intended for use against a financial obligation arising from a financial product. The method may include disposing of the benefit. The disposing may include debt deferment, debt suspension, debt cancellation, or debt forgiveness. The trigger event may be a loss of employment, divorce, disability, hospitalization, medical treatment, family leave, judicial proceedings, tax events, natural disasters, call to duty, fire, flood, marriage, child birth, child adoption, retirement, or death. The payment obligation may be a loan (e.g., mortgage), bill (e.g., health insurance bill, life insurance bill, rent, utility bill, hospital bill, credit card bill, car insurance bill), car payment (e.g., payment on a car loan or lease), retirement savings, penalty, fine, attorney fees, tax, other type of lease, line of credit, letter of credit payment, or child support. The embodiment may include a financial product such as a credit card, a stored value card, a demand deposit account, a letter of credit, or a line of credit. The embodiment may include a web page accessible by the entity, where the step of receiving data selected by the entity occurs via the website. The embodiment may include conveying to the entity, via the website, information reflecting at least one fee received from the entity. The embodiment may further comprise receiving an application from the entity, the application including the information relating to the entity, and accepting the application. The embodiment may further include receiving consideration. The consideration may include at least one fee received from the entity, at least a portion of the fee being associated with the benefit. The portion of the at least one fee associated with the benefit may include a flat fee, a lump sum fee, a percentage of a periodic obligation, a percentage of an outstanding debt, or a percentage of an average monthly balance. The consideration may include the entity obtaining an account. No compensation may be received in response to the step of issuing.


The embodiment may include receiving data selected by the entity. Such data, being associated with the account, may include third information reflecting a second trigger circumstance, the third information defining a potential future situation, and fourth information reflecting a second benefit, the second benefit being intended to address at least one payment obligation. Such an embodiment may further include receiving a request, the request indicating that a trigger circumstance has occurred, and comparing information in the request to account information associated with the entity. Such an embodiment may further include determining, based on the account information associated with the entity and consistent with the data received from the entity, that the entity is entitled to a triggered benefit, the triggered benefit being the benefit or the second benefit, and providing the triggered benefit to the entity in accordance with the account information associated with the entity.





BRIEF DESCRIPTION OF THE DRAWINGS

The invention, both as to its structure and operation together with the additional objects and advantages thereof are best understood through the following description of exemplary embodiments of the present invention when read in conjunction with the accompanying drawings.



FIG. 1 is a flowchart illustrating account signup according to an embodiment of the present invention.



FIG. 2 is a flowchart illustrating benefit claiming according to an embodiment of the present invention.



FIG. 3 is a schematic diagram illustrating a web page according to an embodiment of the present invention.





DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

According to an embodiment of the present invention a universal clearinghouse account for payment protection is disclosed. The account is “universal” in the sense that it may be used to protect payment in any of a number of obligations, not limited to debts or obligations associated with the bank that issues the account. Thus, for example, the account may be used to defer a minimum monthly payment on a credit card that is not associated with the account. Such a deferral may be accomplished by issuing a line of credit to the accountholder, where the line of credit may only be used to pay minimum monthly payments on a particular credit card not associated with the account. Obligations (not limited to debts) that may be covered by the invention include, by way of non-limiting example: mortgage payments, secured and unsecured loans and lines of credit (e.g., business or consumer loans), education, credit cards (even credit cards not directly associated with the account or with the financial entity), vehicle payments (e.g., vehicle loans and vehicle leases), vehicle insurance, rent, lease, utilities (e.g., electricity, water, gas), retirement savings (e.g., 401k), penalties, fines, attorney fees, taxes, child support payments, hospital services, and any combination thereof. Any of these payments may be protected even if not initially associated with the account or financial institution. The account may include a credit card or line of credit, but is not limited to accounts that include such products.


According to certain embodiments of the present invention, a single account may provide payment protection for a plurality of financial obligations. Moreover, such embodiments may provide payment protection for obligations that are not initially associated with the account. By way of non-limiting example, certain embodiments of the present invention may include an account with a first bank that provides protection for: the minimum monthly payment on a credit card associated with a second bank, a mortgage payment where the mortgage is held by a third bank, a monthly payment into a 401K savings plan associated with a fourth bank, a car loan payment where the car loan is held by a fifth bank, and so on. In short, certain embodiments of the present invention may provide payment protection for any financial obligation whatsoever, regardless as to whether such obligation is associated with the account that provides the protection.



FIG. 1 is a flowchart illustrating account signup according to an embodiment of the present invention. Account signup may be accomplished by a variety of techniques. The first step 110 is for an entity to submit an application to the issuing bank. Although the term “issuing bank” is used herein, the entity that issues accounts in accordance with embodiments of the present invention is not limited to banks. By way of non-limiting example, banks, credit unions, savings institutions, finance companies, risk pools, or savings & loans may issue such accounts. Thus, the term “issuing bank” is meant to encompass any issuing entity. Further, the term “entity” as used herein, is meant to encompass, by way of non-limiting example, a consumer, a corporation, or a family.


Note that embodiments of the present invention are not limited to submission of the application by the entity. For example, in certain embodiments of the present invention, the application may be submitted by a third-party, such as, by way of non-limiting example, a mortgage holder.


The account associated with an embodiment of the present invention may be a pre-existing account, in which case an application will already be on record. For example, the account may be associated with a mortgage, loan, or other pre-existing financial product associated with the entity. Alternately, an entity may apply for an account by telephone, in person, mail, email or internet. An entity may first be offered an opportunity to obtain an account according to an embodiment of the present invention by solicitation through mail, telephone, email, or any other advertisement technique such as billboard, television ad, or print ad. For telephonic signup, an entity may be solicited by telephone, or the entity may initiate the contact him or herself by dialing a telephone number that has been provided by any of the above-referenced advertisement techniques, for example. For mail signup, the entity may fill out a form and return it in a pre-paid envelope. The entity may obtain such a faun, by way of non-limiting example, via its inclusion with a bill or other communication associated with a pre-existing account. For internet-based signup, the entity may visit a webpage and fill out a form. A link to such a webpage may appear on any content website or may be included in an emailed solicitation.


Once the entity (or other party) has submitted an application, the issuing bank determines whether it will accept 120 the application. Acceptance involves conventional risk-determination techniques, such as checking the applicant's credit. Further, the issuing bank may check its own records for the applicant should the applicant already be a customer of the issuing bank. Part of the determination typically involves screening the applicant according to normal screening procedures associated with any financial products that form part of the account. For example, for an embodiment of the present invention that includes a credit card, the acceptance process would typically include a screening of applicants similar or identical to a screening of applicants that would precede issuing such a credit card that is not associated with an embodiment of the present invention. For an embodiment of the present invention that includes a savings account only, the process will typically include the screening that an applicant would undergo upon application for a standard savings account. In sum, the financial product or products associated with an embodiment of the present invention typically define, in part, the screening process that an applicant will undergo. As discussed further below, such an initial screening process may be independent from a secondary screening process that is associated with requesting trigger events and their corresponding benefits.


Once the application is accepted, the customer may select trigger events and associated benefits 130. Note that in certain embodiments of the present invention, the accountholder may choose trigger events and associated benefits contemporaneously with his or her application submission 110. Trigger events generally initiate payment protection in accordance with certain embodiments of the present invention. Such events include, by way of non-limiting example, involuntary loss of employment, divorce, bankruptcy, disability, death judicial proceedings, tax events, natural disasters, and hospitalization. The accountholder may select trigger events from a list of possibilities that are displayed to the accountholder via, by way of non-limiting example, the internet, email, traditional mail, or telephone. Alternately, or in addition, the customer may define a trigger event him or herself. The customer may select any number of trigger events.


Benefits available according to certain embodiments of the present invention include deferring mandatory payments (e.g., monthly minimum payments) for a certain amount of time and without incurring interest, and/or extending one or more lines of credit (which may be done automatically by, e.g., via wire transfer to an account, adding credit to a credit card, or by adding to or distributing a stored value card). The type of protection invoked upon a trigger event may depend on the particular type of trigger event itself. Benefits may survive death of the accountholder.


Other types of benefits include one or more lines of credit. Such lines of credit may be limited to certain merchants by, for example, making the money available on the card associated with the account and limiting the card for use with particular merchants via a merchant code. Alternately, or in addition, certain embodiments of the invention may extend a generic line of credit, such that a trigger event causes a line of credit of a particular amount to be extended for any use whatsoever. In either the limited or generic case, a line of credit may be automatically entered onto the balance of a card associated with the account such as a credit or stored value card. Lines of credit extended as benefits according to certain embodiments of the present inventions may be drawn upon to retire up to a certain number of full or partial periodic payment obligations and/or full or partial debt balances.


A benefit may include a line of credit specifically targeted to paying obligations associated with a financial product that does not form part of the universal payment protection account. That is, an accountholder may possess a financial instrument, such as a credit card, that is not part of an account associated with an embodiment of the present invention. Such a financial product is referred to herein as an “outside financial product.” Such an outside financial product may have a payment obligation associated with it, such as a minimum monthly payment for a credit card. A benefit according to an embodiment of the present invention may include a line of credit that is specifically configured to pay obligations associated with outside financial products. In the example of a outside financial product credit card, a benefit may be a line of credit that covers the minimum monthly payments. Such a line of credit may be restricted for payment of that credit card only.


Note that embodiments of the present invention may be used to protect payment obligations for any of a variety of outside financial products such as, by way of non-limiting example, mortgages, loans such as car loans, savings accounts such as 401k accounts, and credit cards. Such line of credit benefits may be unrestricted, or may be restricted for use against any financial obligation including financial obligations associated with any financial product, whether an outside financial product or not.


Note also that payment protection of an outside financial product survives transfer of that outside financial product to another entity. For example, if an outside mortgage is protected, protection will survive the mortgage holder selling the mortgage to another entity. This is unlike e.g., prior art mortgage protection services where the mortgage protection is provided by the same entity that holds the mortgage.


Each trigger event is generally associated with at least one benefit. Likewise, each benefit is generally associated with at least one trigger event. As an example of a trigger event and benefit pair, certain embodiment of the present invention may include payment holidays. For example, embodiments of the present invention may offer the entity a set of certain predetermined days on which the entity may declare that a trigger event has occurred. A set of such predetermined days may typically, but not necessarily, include federal holidays. Thus, for example, once the entity selects such a set of days as part of selecting trigger events (e.g., at step 130), that entity may use any of the selected days (e.g., Veteran's Day) to declare that a trigger event has occurred. The entity may further select (e.g., at step 130) and eventually receive a benefit associated with such a trigger event. Such a benefit may include any of the benefits discussed herein. Alternately, or in addition, the entity may select a reprieve from an obligation for a limited time (e.g., a payment holiday). Such a reprieve may constitute an interest-free line of credit that automatically extends to the obligation that the entity has selected to be the recipient of the payment holiday.


Typically, the issuing bank calculates a value for each trigger event and associated benefit pair. Such a value is the result of an actuarial analysis of the trigger event, benefit, and accountholder information. The value may be calculated using standard actuarial charts, such as those prepared by or associated with the Society of Actuaries or the Social Security Administration, known to those of skill in the art. Such values generally represent an expected value of the trigger event and benefit pair. Once the issuing bank arrives at a value, it may price the associated payment protection.


Payment protection pricing may be determined as an actuarially-determined expected value plus an additional charge. The additional charge may include consideration of, by way of non-limiting example, administrative costs, marketing costs, competitive analysis, etc. Payment schemes that take into account both an actuarial value and an additional charge include, by way of non-limiting example, a flat monthly fee, a lump-sum fee, a percentage of a monthly obligation (e.g., a percentage of a monthly mortgage payment), a percentage of a total outstanding debt (e.g., a percentage of an entire mortgage), a percentage of an average monthly balance, or any combination of the preceding. Once a total fee is determined using actuarial analysis and other considerations 140, it is included 150 in a bill to the accountholder.



FIG. 2 is a flowchart illustrating benefit claiming according to an embodiment of the present invention. Payment protection is typically invoked by the accountholder notifying 210 the issuing bank of a trigger event. Notification may occur by way of telephone, letter, email, or internet, such as via a webpage-based form. Trigger event notification may occur automatically, without the accountholder's participation. By way of non-limiting example, the issuing bank may receive notification of a death by monitoring coroner's reports or by other means. Once the issuing bank receives notification of a trigger event, it proceeds to retrieve 220 account information associated with the relevant accountholder. The issuing bank will generally retrieve information that reflects each trigger event and benefit pair for which the accountholder has subscribed.


The issuing bank then compares 230 the reported trigger event with those subscribed to by the accountholder and decides whether the accountholder is entitled to one or more benefits. The decision process may further involve inquiries of the accountholder or other parties. By way of non-limiting example, in the event of hospitalization, the accountholder, hospital, or insurer, for example, may be required to produce evidence of hospitalization to the issuing bank. Evidence may take the form of a receipt, insurance report, police report, or other indicia of hospitalization. Evidence may be conveyed automatically, without the participation of the accountholder. In the hospitalization example, the issuing bank may gather receipts, insurance reports, or police reports directly from, respectively, the hospital, the insurer, or the police, without the involvement of the accountholder. In general, additional evidence required by the issuing bank may include, by way of non-limiting example, receipts, official reports, death certificates, court records or orders, police records, sworn statements, verified statements, other statements, telephonic verification with the accountholder or a third party, emailed verification with the accountholder or a third party, and written verification by the accountholder or a third party. Once the issuing bank decides that the accountholder is entitled to one or more benefits, it will provide 240 the same to the accountholder.


The accountholder or other benefit recipient may receive the benefit automatically. Exemplary techniques for such automatic transfer include, by way of non-limiting example, check, direct deposit, or wire transfer to the accountholder or directly to the party to whom the obligation is due, or by addition to or distribution of a stored value card. Automatic transfer may include activation of a stored value card, e.g., using the techniques taught in U.S. Pat. No. 6,615,190 to Slater entitled “Sponsor-Funded Stored Value Card.”


At step 250, the benefit is optionally disposed of. That is, certain embodiments of the present invention cancel or suspend without interest the debt incurred by accepting a benefit. The disposition of a debt arising from a benefit may be predetermined based on the terms and conditions of the debt protection agreement options selected and actively in place. That is, selecting a disposal option may occur as part of selecting benefits and trigger events. In certain embodiments, a line of credit specifically configured for payment of obligations associated with an outside financial product serves to effectively defer payment of those obligations until such time that repayment of the line of credit is due. However, certain embodiments may dispose of the benefit by entirely forgiving debt arising from the line of credit. In such embodiments, the disposal of the benefit may serve to effectively cancel outside financial product payment obligation altogether.



FIG. 3 is a schematic diagram illustrating a web page 310 according to an embodiment of the present invention. Such a web page may include a heading 320, which identifies the issuing bank or the payment protection program. The web page may require an accountholder to log in at portion 360 with a username and password. The web page may be used to select a trigger event from a list of trigger events 330 and a benefit from a list of benefits 340. The benefits list may dynamically change in response to selecting a trigger event. For example, if an accountholder selects “hospitalization” as a trigger event, the corresponding list of benefits 340 may alter to reflect only those benefits that are relevant upon hospitalization.


The accountholder may use the web page to select the length of time that deferment will last should the accountholder select a deferment benefit. The length of time may be an absolute length of time, e.g., measured in days, a relative length of time, e.g., until the accountholder resumes employment, or a combination of both, e.g., the longer of when the accountholder resumes employment or 100 days. The user may select a length of time from a list or may be able to enter a length of time into a field particularly designed for such a feature. Note that selection of a length of time is not limited to selection via a website; an accountholder may perform such selection telephonically, by way of regular mail, or through any other communication technique.


Embodiments of the present invention may calculate payment options in response to the accountholder's request. That is, when an accountholder selects a trigger event and benefit pair, the issuing bank typically performs an actuarial computation and calculates an associated fee (140 of FIG. 1). The issuing bank may display the fee to the accountholder in real-time on the webpage of FIG. 3 and give the accountholder an opportunity to withdraw or confirm his or her selection. The accountholder may be given an opportunity to modify the selection. For example, if the accountholder selects a deferment benefit of 100 days and decides that the calculated fee is more than the accountholder is willing to pay, the website may give the accountholder the opportunity to select a defer went period with a fewer number of days. Note that presentation of a fee is not limited to presentation via a website. The issuing bank may calculate and convey the fee amount to an accountholder telephonically, by way of regular mail, or through any other communication technique.


The account holder may specify a maximum monthly fee, and the issuing bank may calculate coverage options (trigger events and associated benefits) that are available for that amount. The issuing bank may store a list of the accountholder's payment obligations of which it is aware, and draw from such a list in response to the accountholder's request. For example, the accountholder may specify that he or she is willing to pay $5 per month for some type of payment protection. The issuing bank may determine all trigger event and benefit pairs that are available to that accountholder for such a fee. Alternately, or in addition, the accountholder may narrow the field of trigger events and/or benefits that are subject to this feature. For example, the accountholder may be interested in all deferments that are available for $5 per month on any of a variety of payment obligations. The issuing bank may then offer the accountholder a choice of payment obligations that it may defer for a fee of $5 per month. Note that presentation of trigger events and/or benefits is not limited to presentation via a website. The issuing bank may convey such options to an accountholder telephonically, by way of regular mail, or through any other communication technique.


The accountholder may specify on the website a hierarchy of debts to be paid in order upon certain trigger events. That is, where the accountholder selects debt cancellation as a benefit, he or she may further specify which debts should be cancelled in order. Specifying the order of debt cancellation may be accomplished via the web page or any other communication channel, such as telephone, mail, or email.


The accountholder may designate individuals that are to receive funds via stored value cards or other techniques upon certain trigger events. More generally, certain embodiments of the present invention allow persons other than the accountholder to receive benefits. Such persons may be specified on the web page during account signup (e.g., 130 of FIG. 1), or at any other time. Further, specifying benefit recipients may be accomplished via telephone, email, regular mail, or any other communications channel.


The web page may include a trigger event reporting feature 350. Such a feature may include a list of trigger events that the accountholder has selected and been approved for. The accountholder may use the reporting feature to report trigger events to the issuing bank. By way of non-limiting example, the reporting feature may allow the accountholder to click on a particular trigger event, which will cause a separate dialog screen to appear in which the accountholder may present details of the trigger event. As discussed above in reference to FIG. 2, the issuing bank will then take steps to process the accountholder's information and convey an associated benefit to the accountholder if appropriate.


The web page may be used to check on the status of any outstanding trigger events. By way of non-limiting example, the web page may include a list of trigger events about which the accountholder has notified the issuing bank. The accountholder may click on a listed pending trigger event, by way of non-limiting example, in order to receive information about the issuing bank's processing status of the trigger event. Such information may include an identification of additional information required by the issuing bank. It may further include an estimated time remaining until the accountholder receives the associated benefit.


Certain embodiments of the present invention may incorporate trigger events that are activated by an individual other than the accountholder. By way of non-limiting example, one such trigger event my be an accountholder's spouse involuntarily losing his or her job. As another example, hospitalization of an accountholder's child may trigger cancellation of debt associated with the accountholder. As yet another example, the accountholder may be a minor, who may receive a line of credit restricted for use against a college savings plan in response to the divorce of a parent accountholder. In this latter example, the debt arising from the line of credit may be cancelled in disposing of the benefit. In general, a benefit may protect payment obligations of the accountholder, the person associated with the trigger event, or a third party.


Note that embodiments of the present invention do not provide insurance in the traditional sense, in that they do not pay claims. Instead, certain embodiments of the present invention extend lines of credit. Repayment on these lines of credit may be canceled or deferred.


Advantages of certain embodiments of the present invention include the following. One advantage is a removal of the need for a separate consolidation contract (and signature, in the event of activation) for each separate debt or obligation. Another advantage is that the issuing bank becomes associated with many of the accountholder's obligations. Yet another advantage is that the debt protection liability does not transfer to an owner or investor in the accountholder's obligation because it does not attach to the accountholder's obligation instrument as an amendment. Therefore no prior approval or additional agreements must be made with an owner of or investor in the accountholder's obligation.


The terminology used herein is for the purpose of describing particular embodiments only, and is not intended to limit the scope of the present invention. Unless defined otherwise, all technical, financial and scientific terms used herein have the same meanings as commonly understood by one of ordinary skill in the art to which this invention belongs. As used throughout this disclosure, the singular fauns “a,” “an,” and “the” include plural reference unless the context clearly dictates otherwise.

Claims
  • 1. A computer-implemented method for providing an unrestricted line of credit to an entity from a credit provider, the method comprising: receiving, through a computer, an application from an entity for an unrestricted line of credit which is not limited to payment obligations associated with the credit provider;performing, through the computer, a risk-assessment of the application to determine credit risk of the entity, and upon a determination that the credit risk is acceptable, accepting the application;receiving, through the computer, a selection of trigger event and benefit pairs, each comprising a trigger event and a line of credit associated with each trigger event;calculating, through the computer, a value for each trigger event and benefit pair;calculating, through the computer, a payment protection price for each trigger event and benefit pair;issuing the payment protection price for each selected trigger event and benefit pair for payment by the entity;receiving notification that a trigger event has occurred;verifying the occurrence of the trigger event; and upon verification of the trigger event;providing, through the computer, the line of credit to the entity associated with the trigger event.
  • 2. The method of claim 1, wherein the calculation of the value of the trigger event and benefit pair comprises at least one probabilistic computation.
  • 3. The method of claim 2, wherein the probabilistic computation comprises at least one financial assessment associated with the trigger event.
  • 4. The method of claim 1, further comprising determining that the entity is entitled to the unrestricted line of credit.
  • 5. The method of claim 1, wherein the unrestricted line of credit is in the form of a check, direct deposit, wire transfer to an account, added funds to a stored value card or distribution of a stored value card.
  • 6. The method of claim 1, wherein trigger event is involuntary loss of employment, disability, hospitalization, child birth, child adoption, retirement, divorce, medical treatment, family leave, judicial proceedings, tax events, natural disasters, call to duty, fire, flood, marriage, bankruptcy or death.
  • 7. The method of claim 1, wherein the payment protection price is in the form of a monthly fee, a lump-sum fee, a percentage of a monthly obligation, a percentage of a total outstanding debt, a percentage of an average monthly balance or any combination thereof.
  • 8. A computer-implemented method for providing a payment protection account to an entity from a credit provider, the method comprising: receiving, through a computer, an application from an entity for a payment protection account;performing, through the computer, a risk-assessment of the application to determine credit risk of the entity, and upon a determination that the credit risk is acceptable, accepting the application;providing the payment protection account to the entity;receiving, through the computer, a selection of trigger event and benefit pairs associated with the payment protection account, each trigger event and benefit pair comprising a trigger event and an unrestricted line of credit associated with each trigger event, wherein the unrestricted line of credit is accessible to the entity upon occurrence of the associated trigger event;calculating, through the computer, a value for each trigger event and benefit pair;calculating, through the computer, a payment protection price for each trigger event and benefit pair;issuing the payment protection price for each selected trigger event and benefit pair for payment by the entity.
  • 9. The method of claim 8, further comprising receiving an indication that the trigger event has occurred.
  • 10. The method of claim 9, further comprising providing the unrestricted line of credit to the entity in response to the indication that the trigger event has occurred.
  • 11. The method of claim 8, further comprising verifying that the trigger event has occurred.
  • 12. The method of claim 8, wherein the unrestricted line of credit is in the form of a check, direct deposit, wire transfer to an account, added funds to a stored value card or distribution of a stored value card.
  • 13. The method of claim 8, wherein trigger event is involuntary loss of employment, disability, hospitalization, child birth, child adoption, retirement, divorce, medical treatment, family leave, judicial proceedings, tax events, natural disasters, call to duty, fire, flood, marriage, bankruptcy or death.
  • 14. The method of claim 8, wherein the payment protection price is in the form of a monthly fee, a lump-sum fee, a percentage of a monthly obligation, a percentage of a total outstanding debt, a percentage of an average monthly balance or any combination thereof.
US Referenced Citations (1096)
Number Name Date Kind
2005003 Patton et al. Jun 1935 A
3230650 Orkin Jan 1966 A
3713235 Roberts Jan 1973 A
3855033 Staats Dec 1974 A
3938090 Borison et al. Feb 1976 A
4022943 Erb et al. May 1977 A
4058220 Torongo Nov 1977 A
D248203 Morse Jun 1978 S
4123747 Lancto et al. Oct 1978 A
4130881 Haessler et al. Dec 1978 A
4205780 Burns et al. Jun 1980 A
4223403 Konheim et al. Sep 1980 A
D259048 Peterson Apr 1981 S
4264808 Owens et al. Apr 1981 A
4319336 Andersen et al. Mar 1982 A
4321672 Braun et al. Mar 1982 A
4338587 Chiappetti Jul 1982 A
4380699 Monnier et al. Apr 1983 A
4453074 Weinstein Jun 1984 A
4454414 Benton Jun 1984 A
4479995 Suzuki et al. Oct 1984 A
4575127 Michel Mar 1986 A
4575621 Dreifus Mar 1986 A
4605820 Campbell, Jr. Aug 1986 A
4605844 Haggan Aug 1986 A
4641239 Takesako Feb 1987 A
4643452 Chang et al. Feb 1987 A
4645701 Zarrow Feb 1987 A
4647714 Goto Mar 1987 A
4648189 Michel Mar 1987 A
4650981 Foletta Mar 1987 A
4661658 Matyas Apr 1987 A
4669730 Small Jun 1987 A
4697072 Kawana Sep 1987 A
4701601 Francini et al. Oct 1987 A
4707594 Roth Nov 1987 A
4713760 Yamada et al. Dec 1987 A
4723212 O'Brien Feb 1988 A
4736094 Yoshida Apr 1988 A
4747620 Kay et al. May 1988 A
4755661 Ruebsam Jul 1988 A
4777563 Teraoka et al. Oct 1988 A
4817949 Bachman et al. Apr 1989 A
4839504 Nakano Jun 1989 A
4845347 McCrindle Jul 1989 A
4851650 Kitade Jul 1989 A
4856857 Takeuchi et al. Aug 1989 A
4859837 Halpern Aug 1989 A
4866545 LaManna et al. Sep 1989 A
4877947 Masu et al. Oct 1989 A
4891503 Jewell Jan 1990 A
D305887 Nishimura Feb 1990 S
4910672 Off Mar 1990 A
4931623 Nakamura et al. Jun 1990 A
4938830 Cannistra Jul 1990 A
4948174 Thomson et al. Aug 1990 A
4953085 Atkins Aug 1990 A
D310386 Michels et al. Sep 1990 S
4977501 Lefevre Dec 1990 A
4986868 Schmidt Jan 1991 A
5023782 Lutz et al. Jun 1991 A
5025139 Halliburton Jun 1991 A
5054096 Beizer Oct 1991 A
5056019 Schultz et al. Oct 1991 A
5072380 Randelman et al. Dec 1991 A
5097115 Ogasawara et al. Mar 1992 A
5121945 Thomson et al. Jun 1992 A
5122950 Mee Jun 1992 A
5140517 Nagata et al. Aug 1992 A
5163098 Dahbura Nov 1992 A
5173851 Off et al. Dec 1992 A
5175682 Higashiyama Dec 1992 A
5177342 Adams Jan 1993 A
5185697 Jacobs et al. Feb 1993 A
5187750 Behera Feb 1993 A
5191522 Bosco et al. Mar 1993 A
5201010 Gabriel Apr 1993 A
5214700 Pinkas et al. May 1993 A
5231569 Myatt et al. Jul 1993 A
5237620 Deaton Aug 1993 A
5239462 Jones Aug 1993 A
5257486 Holmwall Nov 1993 A
5265008 Benton et al. Nov 1993 A
5305196 Deaton et al. Apr 1994 A
5327508 Deaton et al. Jul 1994 A
5351187 Hassett Sep 1994 A
5352877 Morley Oct 1994 A
5361062 Weiss et al. Nov 1994 A
5380046 Stephens Jan 1995 A
5382784 Eberhardt Jan 1995 A
5383687 Suess et al. Jan 1995 A
5388165 Gabriel Feb 1995 A
5409092 Itako et al. Apr 1995 A
5412190 Kopesec May 1995 A
5412192 Hoss May 1995 A
5413341 Lieberman May 1995 A
5428684 Akiyama et al. Jun 1995 A
5430644 Deaton et al. Jul 1995 A
5432326 Noblett et al. Jul 1995 A
5440108 Tran et al. Aug 1995 A
5444794 Uhland Aug 1995 A
5448471 Deaton et al. Sep 1995 A
5450491 McNair Sep 1995 A
5457305 Akel et al. Oct 1995 A
5466920 Nair et al. Nov 1995 A
5481094 Suda Jan 1996 A
5482139 Rivalto Jan 1996 A
5489123 Roshkoff Feb 1996 A
5495981 Warther Mar 1996 A
5500890 Rogge et al. Mar 1996 A
5503891 Marshall et al. Apr 1996 A
5532689 Bueno Jul 1996 A
5539825 Akiyama et al. Jul 1996 A
5541583 Mandelbaum Jul 1996 A
5546446 Tsunokawa et al. Aug 1996 A
5557092 Ackley et al. Sep 1996 A
5557516 Hogan Sep 1996 A
5563934 Eda Oct 1996 A
5572004 Raimann Nov 1996 A
5583933 Mark Dec 1996 A
5609253 Goade, Sr. Mar 1997 A
5617474 Ditzig et al. Apr 1997 A
5619558 Jheeta Apr 1997 A
5621787 McKoy et al. Apr 1997 A
5621812 Deaton et al. Apr 1997 A
5637845 Kolls Jun 1997 A
5638457 Deaton et al. Jun 1997 A
5642279 Stone Jun 1997 A
5642485 Deaton et al. Jun 1997 A
5649118 Carlisle et al. Jul 1997 A
5650604 Marcous et al. Jul 1997 A
5652786 Rogers Jul 1997 A
5659469 Deaton et al. Aug 1997 A
5677521 Garrou Oct 1997 A
5680459 Hook et al. Oct 1997 A
5698837 Furuta Dec 1997 A
5704044 Tarter et al. Dec 1997 A
5715298 Rogers Feb 1998 A
5732136 Murphree et al. Mar 1998 A
5744787 Teicher Apr 1998 A
5745555 Mark Apr 1998 A
5748737 Daggar May 1998 A
5774882 Keen Jun 1998 A
5787403 Randle Jul 1998 A
5789732 McMahon et al. Aug 1998 A
5790636 Marshall Aug 1998 A
5796827 Coppersmith et al. Aug 1998 A
5797133 Jones Aug 1998 A
5798950 Fitzgerald Aug 1998 A
5806042 Kelly et al. Sep 1998 A
5806047 Hackel et al. Sep 1998 A
5814796 Benson et al. Sep 1998 A
5825871 Mark Oct 1998 A
5826243 Musmanno et al. Oct 1998 A
5832090 Raspotnik Nov 1998 A
5842421 Desilets et al. Dec 1998 A
5870456 Rogers Feb 1999 A
5877975 Jigour et al. Mar 1999 A
D408054 Leedy, Jr. Apr 1999 S
5897621 Boesch et al. Apr 1999 A
5901303 Chew May 1999 A
5903879 Mitchell May 1999 A
5907142 Kelsey May 1999 A
5907828 Meyer et al. May 1999 A
5907831 Lotvin et al. May 1999 A
5918211 Sloane Jun 1999 A
5926792 Koppes et al. Jul 1999 A
5928082 Clapper, Jr. Jul 1999 A
5933812 Meyer et al. Aug 1999 A
5936221 Corder et al. Aug 1999 A
5946669 Polk Aug 1999 A
5949044 Walker et al. Sep 1999 A
5956711 Sullivan et al. Sep 1999 A
5960411 Hartman et al. Sep 1999 A
5963925 Kolling et al. Oct 1999 A
5970469 Scroggie et al. Oct 1999 A
5970478 Walker et al. Oct 1999 A
5979757 Tracy Nov 1999 A
5991736 Ferguson et al. Nov 1999 A
5999596 Walker et al. Dec 1999 A
5999624 Hopkins Dec 1999 A
5999917 Facciani et al. Dec 1999 A
6006205 Loeb et al. Dec 1999 A
6009411 Kepecs Dec 1999 A
6012049 Kawan Jan 2000 A
6014634 Scroggie et al. Jan 2000 A
6018718 Walker et al. Jan 2000 A
6021189 Vu Feb 2000 A
6024286 Bradley et al. Feb 2000 A
6025283 Roberts Feb 2000 A
6029144 Barrett et al. Feb 2000 A
6029153 Bauchner et al. Feb 2000 A
6032859 Muehlberger et al. Mar 2000 A
6044360 Picciallo Mar 2000 A
6045050 Ippolito et al. Apr 2000 A
6048271 Barcelou Apr 2000 A
6055573 Gardenswartz et al. Apr 2000 A
6061660 Eggleston et al. May 2000 A
D427167 Iwasaki Jun 2000 S
6085976 Sehr Jul 2000 A
6089284 Kaehler et al. Jul 2000 A
6092057 Zimmermann et al. Jul 2000 A
6105006 Davis et al. Aug 2000 A
6105007 Norris Aug 2000 A
6105008 Davis et al. Aug 2000 A
6105009 Cuervo Aug 2000 A
6108642 Findley Aug 2000 A
6109525 Blomqvist et al. Aug 2000 A
6112190 Fletcher et al. Aug 2000 A
6112191 Burke Aug 2000 A
6119097 Ibarra Sep 2000 A
6119103 Basch et al. Sep 2000 A
6119107 Polk Sep 2000 A
6119933 Wong et al. Sep 2000 A
6129572 Feldman et al. Oct 2000 A
6134309 Carson Oct 2000 A
6138911 Fredregill et al. Oct 2000 A
6141666 Tobin Oct 2000 A
6142640 Schofield Nov 2000 A
6144848 Walsh et al. Nov 2000 A
6148293 King Nov 2000 A
6163771 Walker et al. Dec 2000 A
6164548 Curiel Dec 2000 A
6169974 Baumgartner et al. Jan 2001 B1
6179211 Green et al. Jan 2001 B1
6182059 Angotti et al. Jan 2001 B1
D437882 Creighton Feb 2001 S
6185541 Scroggie et al. Feb 2001 B1
6188309 Levine Feb 2001 B1
6192113 Lorsch Feb 2001 B1
6192142 Pare, Jr. et al. Feb 2001 B1
6213392 Zuppichich Apr 2001 B1
6222914 McMullin Apr 2001 B1
6223143 Weinstock et al. Apr 2001 B1
D442627 Webb et al. May 2001 S
6227445 Brookner May 2001 B1
6227972 Walker et al. May 2001 B1
6243689 Norton Jun 2001 B1
6260758 Blumberg Jul 2001 B1
6267292 Walker et al. Jul 2001 B1
6278996 Richardson et al. Aug 2001 B1
6282516 Giullani Aug 2001 B1
6289322 Kitchen et al. Sep 2001 B1
6289324 Kawan Sep 2001 B1
6292786 Deaton et al. Sep 2001 B1
6295344 Marshall Sep 2001 B1
D449336 Webb et al. Oct 2001 S
6302444 Cobben Oct 2001 B1
6308887 Korman et al. Oct 2001 B1
6315193 Hogan Nov 2001 B1
6315195 Ramachandran Nov 2001 B1
6315196 Bachman Nov 2001 B1
6321211 Dodd Nov 2001 B1
6324524 Lent et al. Nov 2001 B1
6324526 D'Agostino Nov 2001 B1
6327573 Walker et al. Dec 2001 B1
6327575 Katz Dec 2001 B1
6330543 Kepecs Dec 2001 B1
6330546 Gopinathan et al. Dec 2001 B1
6332126 Peirce et al. Dec 2001 B1
6334108 Deaton et al. Dec 2001 B1
6338048 Mori Jan 2002 B1
6344108 Von Medvey et al. Feb 2002 B1
6349290 Horowitz et al. Feb 2002 B1
6349972 Geiger et al. Feb 2002 B1
6351735 Deaton et al. Feb 2002 B1
6356881 Milch et al. Mar 2002 B1
6360209 Loeb et al. Mar 2002 B1
6366967 Wagner Apr 2002 B1
6374230 Walker et al. Apr 2002 B1
6377669 Walker et al. Apr 2002 B1
6377935 Deaton et al. Apr 2002 B1
6382677 Kaule et al. May 2002 B1
6385594 Lebda et al. May 2002 B1
6404866 Hopper et al. Jun 2002 B1
6405175 Ng Jun 2002 B1
6405181 Lent et al. Jun 2002 B2
6409080 Kawagishi Jun 2002 B2
6409593 Petrecca Jun 2002 B1
6411947 Rice et al. Jun 2002 B1
6419161 Haddad Jul 2002 B1
6424947 Tsuria et al. Jul 2002 B1
6424949 Deaton et al. Jul 2002 B1
6424951 Shurling et al. Jul 2002 B1
6434534 Walker et al. Aug 2002 B1
D462477 Osborne Sep 2002 S
6454647 Woodbury, Jr. Sep 2002 B1
6456981 Dejaeger et al. Sep 2002 B1
6470306 Pringle et al. Oct 2002 B1
6471128 Corcoran et al. Oct 2002 B1
6481125 Pokrasoff Nov 2002 B1
6484146 Day et al. Nov 2002 B2
6484428 Greenwald et al. Nov 2002 B1
D466929 Haas Dec 2002 S
D467271 Haas Dec 2002 S
D467272 Haas Dec 2002 S
6488206 Flaig et al. Dec 2002 B1
6490568 Omara et al. Dec 2002 B1
6491782 Jaynes Dec 2002 B1
D468789 Arnold et al. Jan 2003 S
6505095 Kolls Jan 2003 B1
6505780 Yassin et al. Jan 2003 B1
6507644 Henderson et al. Jan 2003 B1
6513019 Lewis Jan 2003 B2
6516302 Deaton et al. Feb 2003 B1
6529880 McKeen et al. Mar 2003 B1
6553113 Dhir et al. Apr 2003 B1
6557039 Leong et al. Apr 2003 B1
D474235 Haas May 2003 S
6557750 Druse et al. May 2003 B1
6557766 Leighton May 2003 B1
6558255 Walker et al. May 2003 B2
6560581 Fox et al. May 2003 B1
6561657 Schofield May 2003 B1
6564189 Nycz May 2003 B1
6567786 Bibelnieks et al. May 2003 B1
6567791 Lent et al. May 2003 B2
6567821 Polk May 2003 B1
6571216 Garg et al. May 2003 B1
6575361 Graves et al. Jun 2003 B1
6578012 Storey Jun 2003 B1
6581831 Madani Jun 2003 B2
6581845 Ye Jun 2003 B2
D476681 Al Amri Jul 2003 S
D476683 Kilburn Jul 2003 S
D477359 Haas Jul 2003 S
D477634 Malone Jul 2003 S
6592044 Wong et al. Jul 2003 B1
6595342 Maritzen et al. Jul 2003 B1
6601040 Kolls Jul 2003 B1
6607127 Wong Aug 2003 B2
6609104 Deaton et al. Aug 2003 B1
6609113 O'Leary et al. Aug 2003 B1
6609654 Anderson et al. Aug 2003 B1
6609658 Sehr Aug 2003 B1
6611811 Deaton et al. Aug 2003 B1
6611819 Oneda Aug 2003 B1
6615189 Phillips et al. Sep 2003 B1
6615190 Slater Sep 2003 B1
D481067 Haas Oct 2003 S
D481068 Blossom et al. Oct 2003 S
6644551 Clayman et al. Nov 2003 B2
6647374 Kansal Nov 2003 B2
6647376 Farrar et al. Nov 2003 B1
D483407 Ramnarine Dec 2003 S
6655587 Andrews et al. Dec 2003 B2
6655598 Curiel Dec 2003 B1
6659259 Knox et al. Dec 2003 B2
6662215 Moskowitz et al. Dec 2003 B1
6665687 Burke Dec 2003 B1
6671673 Baseman et al. Dec 2003 B1
D485573 Li Jan 2004 S
6675149 Ruffin et al. Jan 2004 B1
6684195 Deaton et al. Jan 2004 B1
6697799 Neal et al. Feb 2004 B1
6705518 Park et al. Mar 2004 B2
6715797 Curiel Apr 2004 B2
6718313 Lent et al. Apr 2004 B1
6721743 Sakakibara Apr 2004 B1
6726813 Kaule et al. Apr 2004 B2
6727802 Kelly et al. Apr 2004 B2
6732919 Macklin et al. May 2004 B2
6742125 Gabber et al. May 2004 B1
D490840 Arakaki et al. Jun 2004 S
D491186 Arakaki et al. Jun 2004 S
D491953 Arakaki et al. Jun 2004 S
6754640 Bozeman Jun 2004 B2
6757660 Canada et al. Jun 2004 B2
6757710 Reed Jun 2004 B2
D493195 Creighton Jul 2004 S
6764014 Lasch et al. Jul 2004 B2
D495736 Scharf Sep 2004 S
D496365 Liu et al. Sep 2004 S
6793131 Hogan Sep 2004 B2
6793135 Ryoo Sep 2004 B1
6795809 O'Brien et al. Sep 2004 B2
6795812 Lent et al. Sep 2004 B1
6804786 Chamley et al. Oct 2004 B1
6805288 Routhenstein et al. Oct 2004 B2
6805289 Noriega et al. Oct 2004 B2
D498236 Liu et al. Nov 2004 S
6814282 Seifert et al. Nov 2004 B2
6817008 Ledford et al. Nov 2004 B2
6819748 Matada Nov 2004 B2
6820061 Postrel Nov 2004 B2
6829586 Postrel Dec 2004 B2
6834796 Anvekar et al. Dec 2004 B2
6842739 Postrel Jan 2005 B2
6845906 Royer et al. Jan 2005 B2
D501875 Dean Feb 2005 S
6856973 Bott Feb 2005 B1
6857566 Wankmueller Feb 2005 B2
RE38717 Bothwell Mar 2005 E
6871174 Dolan et al. Mar 2005 B1
6874139 Krueger et al. Mar 2005 B2
6880084 Brittenham et al. Apr 2005 B1
6885994 Scroggie et al. Apr 2005 B1
6886046 Stutz et al. Apr 2005 B2
D505450 Lauer et al. May 2005 S
6886741 Salveson May 2005 B1
6889198 Kawan May 2005 B2
6892187 Phillips et al. May 2005 B2
6895383 Heinrich May 2005 B2
6895386 Bachman et al. May 2005 B1
6901375 Fernandez May 2005 B2
6901406 Nabe et al. May 2005 B2
6912502 Buddle et al. Jun 2005 B1
6913193 Kawan Jul 2005 B1
6915271 Meyer et al. Jul 2005 B1
6920611 Spaeth et al. Jul 2005 B1
6924026 Jaynes Aug 2005 B2
6931382 Laage et al. Aug 2005 B2
6938156 Wheeler et al. Aug 2005 B2
RE38801 Rogers Sep 2005 E
6942156 Ohta et al. Sep 2005 B2
6942569 Petracca Sep 2005 B2
6945453 Schwarz, Jr. Sep 2005 B1
6947898 Postrel Sep 2005 B2
6950940 Wheeler et al. Sep 2005 B2
6954741 Burchetta et al. Oct 2005 B1
6961710 Yanagisawa et al. Nov 2005 B1
6963857 Johnson Nov 2005 B1
6968348 Carone et al. Nov 2005 B1
6970830 Samra et al. Nov 2005 B1
6978369 Wheeler et al. Dec 2005 B2
6985873 Sullivan Jan 2006 B2
6985879 Walker et al. Jan 2006 B2
6999569 Risafi et al. Feb 2006 B2
6999938 Libman Feb 2006 B1
6999943 Johnson et al. Feb 2006 B1
7003476 Samra et al. Feb 2006 B1
7006979 Samra et al. Feb 2006 B1
7010495 Samra et al. Mar 2006 B1
7014110 Minowa et al. Mar 2006 B2
7024374 Day et al. Apr 2006 B1
7025256 Drummond et al. Apr 2006 B1
7031908 Huang et al. Apr 2006 B1
7031939 Gallagher et al. Apr 2006 B1
7039600 Meek et al. May 2006 B1
7047222 Bush May 2006 B1
7050996 Blagg et al. May 2006 B1
7051001 Slater May 2006 B1
7051925 Schwarz, Jr. May 2006 B2
7051929 Li May 2006 B2
7054842 James et al. May 2006 B2
7062031 Becerra et al. Jun 2006 B2
7063924 Kaminsky et al. Jun 2006 B2
7066382 Kaplan Jun 2006 B2
7069244 Strayer et al. Jun 2006 B2
D524859 Graves et al. Jul 2006 S
7070095 Gandel et al. Jul 2006 B1
7072864 Brake, Jr. et al. Jul 2006 B2
7072909 Polk Jul 2006 B2
7076458 Lawlor et al. Jul 2006 B2
7076465 Blagg et al. Jul 2006 B1
7082416 Anderson Jul 2006 B2
7083084 Graves et al. Aug 2006 B2
7089202 McNamar et al. Aug 2006 B1
7089503 Bloomquist et al. Aug 2006 B1
7090138 Rettenmyer et al. Aug 2006 B2
7092905 Behrenbrinker et al. Aug 2006 B2
7092916 Diveley Aug 2006 B2
7104443 Paul et al. Sep 2006 B1
7107249 Dively Sep 2006 B2
7113914 Spielmann et al. Sep 2006 B1
D530741 Blossom Oct 2006 S
7120601 Chen et al. Oct 2006 B2
7121471 Beenau et al. Oct 2006 B2
7128272 Doublet Oct 2006 B2
7143063 Lent et al. Nov 2006 B2
D533220 Graves et al. Dec 2006 S
7156301 Bonalle et al. Jan 2007 B1
7163153 Blossom Jan 2007 B2
7165049 Slater Jan 2007 B2
7167844 Leong et al. Jan 2007 B1
7171385 Dembo et al. Jan 2007 B1
7184973 Monteleone et al. Feb 2007 B2
D538349 Hollands Mar 2007 S
7191952 Blossom Mar 2007 B2
7195154 Routhenstein Mar 2007 B2
7216091 Blandina et al. May 2007 B1
7216099 Chen et al. May 2007 B2
7225155 Polk May 2007 B1
7228155 Saunders Jun 2007 B2
7239226 Berardi et al. Jul 2007 B2
7243839 Beck et al. Jul 2007 B2
7249092 Dunn et al. Jul 2007 B2
7249097 Hutchison et al. Jul 2007 B2
7249099 Ling Jul 2007 B2
7249112 Berardi et al. Jul 2007 B2
7252223 Schofield Aug 2007 B2
7252226 Risafi et al. Aug 2007 B2
7254560 Singhal Aug 2007 B2
7260549 Spielmann et al. Aug 2007 B2
D551705 Mershon Sep 2007 S
7266524 Butcher, III Sep 2007 B1
7269737 Robinson Sep 2007 B2
7275160 Pearson et al. Sep 2007 B2
7295999 Simon et al. Nov 2007 B1
7306141 Schwarz Dec 2007 B1
7306163 Scholz et al. Dec 2007 B2
7310617 Cunningham Dec 2007 B1
7311244 Schwarz, Jr. Dec 2007 B1
7312707 Bishop et al. Dec 2007 B1
7315843 Diveley et al. Jan 2008 B2
7318049 Iannacci Jan 2008 B2
D562888 Brown Feb 2008 S
7333948 Bell et al. Feb 2008 B2
7340431 McManus et al. Mar 2008 B1
7346562 Inoue et al. Mar 2008 B2
7346567 Weeks Mar 2008 B2
7349866 Schwarz, Jr. Mar 2008 B2
7356516 Richey et al. Apr 2008 B2
7357331 Blossom Apr 2008 B2
7359880 Abel et al. Apr 2008 B2
7360693 Sullivan Apr 2008 B1
7370004 Patel et al. May 2008 B1
7373304 Pletz et al. May 2008 B1
7392221 Nabe et al. Jun 2008 B2
7392222 Hamilton et al. Jun 2008 B1
7392224 Bauer et al. Jun 2008 B1
7398241 Fay et al. Jul 2008 B2
7398248 Phillips et al. Jul 2008 B2
7401049 Hobbs et al. Jul 2008 B2
7401731 Pletz et al. Jul 2008 B1
7406426 Pletz et al. Jul 2008 B1
D576671 Field et al. Sep 2008 S
D582476 Field et al. Dec 2008 S
D582977 Field et al. Dec 2008 S
7461028 Wronski, Jr. Dec 2008 B2
7467096 Antonucci et al. Dec 2008 B2
7479320 Keller et al. Jan 2009 B2
7493288 Biship et al. Feb 2009 B2
7494057 Lasch et al. Feb 2009 B2
7502758 Burke Mar 2009 B2
7503503 Riedl et al. Mar 2009 B2
7506804 Zajkowski et al. Mar 2009 B2
7506806 Bonalle et al. Mar 2009 B2
7512551 Postrel Mar 2009 B2
7523385 Nguyen et al. Apr 2009 B2
7530491 Lasch et al. May 2009 B2
7580857 VanFleet et al. Aug 2009 B2
7587363 Cataline et al. Sep 2009 B2
7588184 Gandel et al. Sep 2009 B2
7591416 Blossom Sep 2009 B2
D602522 Field et al. Oct 2009 S
D602986 Skelding et al. Oct 2009 S
7606730 Antonucci Oct 2009 B2
7613629 Antonucci et al. Nov 2009 B2
7630935 Loeger et al. Dec 2009 B2
7640205 Michelassi et al. Dec 2009 B2
7660763 Brake, Jr. et al. Feb 2010 B1
7676425 Noles Mar 2010 B1
7676459 Carone et al. Mar 2010 B2
7686218 Hessburg et al. Mar 2010 B2
7689504 Warren et al. Mar 2010 B2
7707111 Brake, Jr. et al. Apr 2010 B2
7720699 Santoloci May 2010 B2
7729925 Maritzen et al. Jun 2010 B2
7729980 Mittenzwei et al. Jun 2010 B2
7742970 Thierer et al. Jun 2010 B2
7747463 Phillips et al. Jun 2010 B1
7753259 Taylor et al. Jul 2010 B1
20010001856 Gould et al. May 2001 A1
20010002487 Grawrock et al. May 2001 A1
20010014868 Herz et al. Aug 2001 A1
20010023407 Liyanearachchi et al. Sep 2001 A1
20010025253 Heintz et al. Sep 2001 A1
20010027389 Beverina et al. Oct 2001 A1
20010029490 Inamochi Oct 2001 A1
20010034647 Marks et al. Oct 2001 A1
20010034651 Marks et al. Oct 2001 A1
20010034663 Teveler et al. Oct 2001 A1
20010034684 Cushing et al. Oct 2001 A1
20010034718 Shaked et al. Oct 2001 A1
20010034720 Armes Oct 2001 A1
20010037243 Rouston et al. Nov 2001 A1
20010037276 Kelly et al. Nov 2001 A1
20010037299 Nichols et al. Nov 2001 A1
20010038033 Habib Nov 2001 A1
20010039511 Duckworth et al. Nov 2001 A1
20010044733 Lee et al. Nov 2001 A1
20010044764 Arnold Nov 2001 A1
20010047332 Gonen-Friedman et al. Nov 2001 A1
20010049628 Icho Dec 2001 A1
20010051917 Bissonette et al. Dec 2001 A1
20010056399 Saylors Dec 2001 A1
20020002495 Ullman Jan 2002 A1
20020004742 Willcocks et al. Jan 2002 A1
20020007313 Mai et al. Jan 2002 A1
20020010591 Pomerance Jan 2002 A1
20020010621 Bell et al. Jan 2002 A1
20020011517 Namekawa et al. Jan 2002 A1
20020013751 Facciani et al. Jan 2002 A1
20020019793 Frattalone Feb 2002 A1
20020026365 Natanzon Feb 2002 A1
20020026416 Provinse Feb 2002 A1
20020029191 Ishibashi et al. Mar 2002 A1
20020032609 Wilkman Mar 2002 A1
20020032622 Petit et al. Mar 2002 A1
20020035527 Corrin Mar 2002 A1
20020040344 Preiser et al. Apr 2002 A1
20020042742 Glover et al. Apr 2002 A1
20020042774 Ortiz et al. Apr 2002 A1
20020046089 Zorn Apr 2002 A1
20020046106 Ishibashi et al. Apr 2002 A1
20020046110 Gallagher Apr 2002 A1
20020046116 Hohle et al. Apr 2002 A1
20020049605 Hagi Apr 2002 A1
20020052778 Murphy et al. May 2002 A1
20020055874 Cohen May 2002 A1
20020059103 Anderson et al. May 2002 A1
20020059139 Evans May 2002 A1
20020062249 Iannacci May 2002 A1
20020062253 Dosh et al. May 2002 A1
20020062257 Minamishin et al. May 2002 A1
20020065720 Carswell et al. May 2002 A1
20020065735 Hatakama et al. May 2002 A1
20020069104 Beach et al. Jun 2002 A1
20020069109 Wendkos Jun 2002 A1
20020069122 Yun et al. Jun 2002 A1
20020069158 Larkin et al. Jun 2002 A1
20020070270 Narita et al. Jun 2002 A1
20020070976 Tanner et al. Jun 2002 A1
20020072931 Card Jun 2002 A1
20020072974 Pugliese et al. Jun 2002 A1
20020073019 Deaton Jun 2002 A1
20020073030 Offer Jun 2002 A1
20020073042 Maritzen et al. Jun 2002 A1
20020077890 LaPointe et al. Jun 2002 A1
20020077895 Howell Jun 2002 A1
20020077904 Ali Jun 2002 A1
20020077964 Brody et al. Jun 2002 A1
20020077966 Harycki et al. Jun 2002 A1
20020082920 Austin et al. Jun 2002 A1
20020082962 Farris et al. Jun 2002 A1
20020082990 Jones Jun 2002 A1
20020087349 Wong Jul 2002 A1
20020087373 Dickstein et al. Jul 2002 A1
20020091567 Royston Jul 2002 A1
20020091632 Turock et al. Jul 2002 A1
20020091634 Eubanks Jul 2002 A1
20020091649 Anvekar et al. Jul 2002 A1
20020099586 Bladen et al. Jul 2002 A1
20020099601 Farrell Jul 2002 A1
20020099649 Lee et al. Jul 2002 A1
20020099667 Diamandis et al. Jul 2002 A1
20020103852 Pushka Aug 2002 A1
20020107731 Teng Aug 2002 A1
20020111859 Sheldon et al. Aug 2002 A1
20020111860 Jones Aug 2002 A1
20020111861 Sakamoto et al. Aug 2002 A1
20020111886 Chenevich et al. Aug 2002 A1
20020111891 Hoffman et al. Aug 2002 A1
20020111916 Coronna et al. Aug 2002 A1
20020116266 Marshall Aug 2002 A1
20020116331 Cataline et al. Aug 2002 A1
20020117541 Biggar et al. Aug 2002 A1
20020120497 King Aug 2002 A1
20020120571 Maung et al. Aug 2002 A1
20020120846 Stewart et al. Aug 2002 A1
20020123926 Bushold et al. Sep 2002 A1
20020123946 Haworth et al. Sep 2002 A1
20020123955 Andreski et al. Sep 2002 A1
20020128916 Beinecke Sep 2002 A1
20020129221 Borgin et al. Sep 2002 A1
20020133401 Mount et al. Sep 2002 A1
20020133461 Ramachandran Sep 2002 A1
20020138409 Bass Sep 2002 A1
20020138418 Zarin et al. Sep 2002 A1
20020143614 MacLean et al. Oct 2002 A1
20020143621 Donnelly et al. Oct 2002 A1
20020143626 Voltmer et al. Oct 2002 A1
20020145039 Carroll Oct 2002 A1
20020147633 Rafizadeh Oct 2002 A1
20020147683 Capobianco et al. Oct 2002 A1
20020147691 Davis et al. Oct 2002 A1
20020152116 Yan et al. Oct 2002 A1
20020152118 Hadjigeorgis Oct 2002 A1
20020152168 Neofytides et al. Oct 2002 A1
20020152179 Racov Oct 2002 A1
20020156723 Lilly et al. Oct 2002 A1
20020161630 Kern et al. Oct 2002 A1
20020161641 Quinlan et al. Oct 2002 A1
20020161699 Okamoto et al. Oct 2002 A1
20020161702 Milberger et al. Oct 2002 A1
20020165771 Walker et al. Nov 2002 A1
20020165808 Zamsky et al. Nov 2002 A1
20020165829 Jones et al. Nov 2002 A1
20020169671 Junger Nov 2002 A1
20020169719 Dively et al. Nov 2002 A1
20020174011 Sanchez et al. Nov 2002 A1
20020174018 Bunger et al. Nov 2002 A1
20020174030 Praisner et al. Nov 2002 A1
20020178025 Hansen et al. Nov 2002 A1
20020178056 Lim Nov 2002 A1
20020178063 Gravelle et al. Nov 2002 A1
20020178112 Goeller et al. Nov 2002 A1
20020187825 Tracy et al. Dec 2002 A1
20020188478 Breeland et al. Dec 2002 A1
20020188509 Ariff et al. Dec 2002 A1
20020188511 Johnson et al. Dec 2002 A1
20020188565 Nakamura et al. Dec 2002 A1
20020190123 Anvekar et al. Dec 2002 A1
20020194071 Yoshizaki et al. Dec 2002 A1
20020194081 Perkowski Dec 2002 A1
20020194098 Stiff et al. Dec 2002 A1
20020194119 Wright et al. Dec 2002 A1
20020198803 Rowe Dec 2002 A1
20020198807 Kobayashi et al. Dec 2002 A1
20020198848 Michener Dec 2002 A1
20030004803 Glover et al. Jan 2003 A1
20030004809 Palcic et al. Jan 2003 A1
20030005288 Moskowitz et al. Jan 2003 A1
20030009358 Greenfeld et al. Jan 2003 A1
20030009374 Moodie et al. Jan 2003 A1
20030009379 Narasimhan et al. Jan 2003 A1
20030009393 Norris Jan 2003 A1
20030010831 Ye Jan 2003 A1
20030018523 Rappaport et al. Jan 2003 A1
20030018613 Oytac Jan 2003 A1
20030023557 Moore Jan 2003 A1
20030028483 Sanders et al. Feb 2003 A1
20030031321 Mages Feb 2003 A1
20030033211 Haines et al. Feb 2003 A1
20030033246 Slater Feb 2003 A1
20030033252 Buttridge et al. Feb 2003 A1
20030034388 Routhenstein et al. Feb 2003 A1
20030036952 Panttaja et al. Feb 2003 A1
20030040927 Sato et al. Feb 2003 A1
20030040959 Fei et al. Feb 2003 A1
20030040964 Lacek Feb 2003 A1
20030046542 Chen et al. Mar 2003 A1
20030048888 Hopper et al. Mar 2003 A1
20030050831 Klayh Mar 2003 A1
20030055780 Hansen et al. Mar 2003 A1
20030055782 Slater Mar 2003 A1
20030061093 Todd Mar 2003 A1
20030061097 Walker et al. Mar 2003 A1
20030061098 Meyer Mar 2003 A1
20030061157 Hirka et al. Mar 2003 A1
20030061168 Routhenstein Mar 2003 A1
20030065618 VanDeBoe, Jr. Apr 2003 A1
20030065624 James et al. Apr 2003 A1
20030069808 Cardno Apr 2003 A1
20030074167 Browne et al. Apr 2003 A1
20030074290 Clore Apr 2003 A1
20030078815 Parsons Apr 2003 A1
20030078881 Elliott et al. Apr 2003 A1
20030083933 McAlear May 2003 A1
20030085272 Andrews et al. May 2003 A1
20030085286 Kelley et al. May 2003 A1
20030088462 Carrither et al. May 2003 A1
20030088470 Cuervo May 2003 A1
20030097298 Klimpl et al. May 2003 A1
20030105688 Brown et al. Jun 2003 A1
20030105689 Chandak et al. Jun 2003 A1
20030105714 Alacron et al. Jun 2003 A1
20030110111 Nalebuff et al. Jun 2003 A1
20030115100 Teicher Jun 2003 A1
20030120544 Gritzbach et al. Jun 2003 A1
20030120571 Blagg Jun 2003 A1
20030125969 Kizer et al. Jul 2003 A1
20030126011 Bryman et al. Jul 2003 A1
20030130940 Hansen et al. Jul 2003 A1
20030130948 Algiene et al. Jul 2003 A1
20030135453 Caulfield et al. Jul 2003 A1
20030135459 Abelman et al. Jul 2003 A1
20030144887 Debber Jul 2003 A1
20030144902 Bowie Jul 2003 A1
20030149629 Claridge et al. Aug 2003 A1
20030149660 Canfield Aug 2003 A1
20030154125 Mittal et al. Aug 2003 A1
20030154163 Phillips et al. Aug 2003 A1
20030158776 Landesmann Aug 2003 A1
20030158782 Thomson et al. Aug 2003 A1
20030158818 George et al. Aug 2003 A1
20030163416 Kitajima Aug 2003 A1
20030167218 Field et al. Sep 2003 A1
20030167220 Schoen et al. Sep 2003 A1
20030171992 Blagg et al. Sep 2003 A1
20030182218 Blagg Sep 2003 A1
20030182246 Johnson et al. Sep 2003 A1
20030182247 Mobed et al. Sep 2003 A1
20030187787 Freund Oct 2003 A1
20030195805 Storey Oct 2003 A1
20030195842 Reece Oct 2003 A1
20030200141 Robison Oct 2003 A1
20030200142 Hicks et al. Oct 2003 A1
20030200143 Walker et al. Oct 2003 A9
20030200179 Kwan Oct 2003 A1
20030204421 Houle et al. Oct 2003 A1
20030205616 Graves Nov 2003 A1
20030205617 Allen et al. Nov 2003 A1
20030208400 Kuo et al. Nov 2003 A1
20030208439 Rast Nov 2003 A1
20030212630 Kahr Nov 2003 A1
20030213843 Jackson Nov 2003 A1
20030216947 Callen et al. Nov 2003 A1
20030216964 MacLean et al. Nov 2003 A1
20030216967 Williams Nov 2003 A1
20030216998 Chang et al. Nov 2003 A1
20030217003 Weinflash et al. Nov 2003 A1
20030217005 Drummond et al. Nov 2003 A1
20030217329 Good Nov 2003 A1
20030218062 Noriega et al. Nov 2003 A1
20030218066 Fernandes et al. Nov 2003 A1
20030220834 Leung et al. Nov 2003 A1
20030222136 Bolle et al. Dec 2003 A1
20030225618 Hessburg et al. Dec 2003 A1
20030225619 Dokken et al. Dec 2003 A1
20030229525 Callahan et al. Dec 2003 A1
20030229579 Savage et al. Dec 2003 A1
20030229590 Byrne et al. Dec 2003 A1
20030233255 Dirienzo Dec 2003 A1
20030233278 Marshall Dec 2003 A1
20030236712 Antonucci et al. Dec 2003 A1
20040002916 Timmerman et al. Jan 2004 A1
20040006487 Tari Jan 2004 A1
20040010447 Asayama Jan 2004 A1
20040010462 Moon et al. Jan 2004 A1
20040015394 Mok et al. Jan 2004 A1
20040024693 Lawrence Feb 2004 A1
20040029569 Khan et al. Feb 2004 A1
20040039686 Klebanoff Feb 2004 A1
20040044606 Buttridge et al. Mar 2004 A1
20040049452 Blagg Mar 2004 A1
20040054619 Watson et al. Mar 2004 A1
20040059952 Newport et al. Mar 2004 A1
20040064332 Zou et al. Apr 2004 A1
20040064401 Palaghita et al. Apr 2004 A1
20040064402 Dreyer et al. Apr 2004 A1
20040078324 Lonnberg et al. Apr 2004 A1
20040078328 Talbert et al. Apr 2004 A1
20040078332 Ferguson et al. Apr 2004 A1
20040088236 Manning May 2004 A1
20040088238 Gilson et al. May 2004 A1
20040093296 Phelan et al. May 2004 A1
20040093303 Picciallo May 2004 A1
20040094624 Fernandes et al. May 2004 A1
20040103431 Davenport et al. May 2004 A1
20040107161 Tanaka et al. Jun 2004 A1
20040111363 Trench et al. Jun 2004 A1
20040111371 Friedman Jun 2004 A1
20040117202 Winklevoss et al. Jun 2004 A1
20040118914 Smith et al. Jun 2004 A1
20040122697 Becerra et al. Jun 2004 A1
20040122736 Strock et al. Jun 2004 A1
20040128186 Breslin et al. Jul 2004 A1
20040128195 Sorem Jul 2004 A1
20040128217 Friedman et al. Jul 2004 A1
20040128248 Fujihara et al. Jul 2004 A1
20040133787 Doughty et al. Jul 2004 A1
20040138991 Song et al. Jul 2004 A1
20040143526 Monasterio et al. Jul 2004 A1
20040149544 Dal Ferro Aug 2004 A1
20040158517 Mahaney et al. Aug 2004 A1
20040159700 Khan et al. Aug 2004 A1
20040172350 Atkinson et al. Sep 2004 A1
20040172358 Lent et al. Sep 2004 A1
20040177036 Nutahara et al. Sep 2004 A1
20040181441 Fung et al. Sep 2004 A1
20040186773 George et al. Sep 2004 A1
20040193539 Sullivan Sep 2004 A1
20040193540 Brown et al. Sep 2004 A1
20040199406 Owens et al. Oct 2004 A1
20040210498 Freund Oct 2004 A1
20040210531 Barron et al. Oct 2004 A1
20040215507 Levitt et al. Oct 2004 A1
20040232223 Beenau et al. Nov 2004 A1
20040236688 Bozeman Nov 2004 A1
20040239481 Beenau Dec 2004 A1
20040242308 Gray Dec 2004 A1
20040243468 Cohagan et al. Dec 2004 A1
20040243506 Das Dec 2004 A1
20040249689 Naraki et al. Dec 2004 A1
20040249710 Smith et al. Dec 2004 A1
20040249712 Brown et al. Dec 2004 A1
20040249764 Delitz et al. Dec 2004 A1
20040252012 Beenau et al. Dec 2004 A1
20050004839 Bakker et al. Jan 2005 A1
20050004864 Lent et al. Jan 2005 A1
20050006286 Fery et al. Jan 2005 A1
20050021353 Aviles et al. Jan 2005 A1
20050021363 Stimson et al. Jan 2005 A1
20050021405 Agarwal Jan 2005 A1
20050021457 Johnson et al. Jan 2005 A1
20050023346 Bakker et al. Feb 2005 A1
20050033619 Barnes et al. Feb 2005 A1
20050033637 Underwood Feb 2005 A1
20050035192 Bonalle et al. Feb 2005 A1
20050035847 Bonalle et al. Feb 2005 A1
20050040242 Beenau et al. Feb 2005 A1
20050049950 Johnson Mar 2005 A1
20050049965 Jen Mar 2005 A1
20050055270 Broe Mar 2005 A1
20050060260 Masuda et al. Mar 2005 A1
20050065877 Cleary et al. Mar 2005 A1
20050071225 Bortolin et al. Mar 2005 A1
20050071226 Nguyen et al. Mar 2005 A1
20050071227 Hammad et al. Mar 2005 A1
20050075889 Gomes et al. Apr 2005 A1
20050077349 Bonalle et al. Apr 2005 A1
20050077350 Courtion et al. Apr 2005 A1
20050080672 Courtion et al. Apr 2005 A1
20050086103 Agura et al. Apr 2005 A1
20050086160 Wong et al. Apr 2005 A1
20050086166 Monk et al. Apr 2005 A1
20050091104 Abraham Apr 2005 A1
20050091492 Benson et al. Apr 2005 A1
20050096976 Nelms May 2005 A1
20050097033 Pretell et al. May 2005 A1
20050102178 Phillips et al. May 2005 A1
20050102228 Srinivasan et al. May 2005 A1
20050108064 Castleman et al. May 2005 A1
20050108090 Takeda et al. May 2005 A1
20050108102 York May 2005 A1
20050108151 York May 2005 A1
20050108152 Tsoa-Lee et al. May 2005 A1
20050114883 Nagai et al. May 2005 A1
20050119938 Smith et al. Jun 2005 A1
20050119979 Murashita Jun 2005 A1
20050125259 Annappindi Jun 2005 A1
20050125292 Kassab et al. Jun 2005 A1
20050125295 Tidwell et al. Jun 2005 A1
20050125296 Tidwell et al. Jun 2005 A1
20050125315 Munoz et al. Jun 2005 A1
20050125337 Tidwell et al. Jun 2005 A1
20050125338 Tidwell et al. Jun 2005 A1
20050125339 Tidwell et al. Jun 2005 A1
20050125350 Tidwell et al. Jun 2005 A1
20050125351 Tidwell et al. Jun 2005 A1
20050125360 Tidwell et al. Jun 2005 A1
20050131761 Trika et al. Jun 2005 A1
20050131792 Rowe Jun 2005 A1
20050135593 Becerra et al. Jun 2005 A1
20050137982 Michelassi et al. Jun 2005 A1
20050144071 Monahan et al. Jun 2005 A1
20050144074 Fredregill et al. Jun 2005 A1
20050144105 Czyzewski Jun 2005 A1
20050144143 Freiberg Jun 2005 A1
20050149386 Agura et al. Jul 2005 A1
20050149393 Leof Jul 2005 A1
20050149440 Michelassi et al. Jul 2005 A1
20050154664 Guy et al. Jul 2005 A1
20050159986 Breeland et al. Jul 2005 A1
20050160003 Berardi et al. Jul 2005 A1
20050160051 Johnson Jul 2005 A1
20050167342 Vullriede et al. Aug 2005 A1
20050167488 Higgins et al. Aug 2005 A1
20050171839 Corriere Aug 2005 A1
20050171842 Tien et al. Aug 2005 A1
20050171901 Rosenblatt et al. Aug 2005 A1
20050177503 Thomas Aug 2005 A1
20050177508 Pembroke Aug 2005 A1
20050177523 Weiss et al. Aug 2005 A1
20050179251 Wagoner et al. Aug 2005 A1
20050182654 Abolfathi et al. Aug 2005 A1
20050182735 Zager et al. Aug 2005 A1
20050187820 Mohan Aug 2005 A1
20050189427 Brown et al. Sep 2005 A1
20050192862 Modi Sep 2005 A1
20050197904 Baron et al. Sep 2005 A1
20050199705 Beck et al. Sep 2005 A1
20050199708 Friedman Sep 2005 A1
20050203824 Freud et al. Sep 2005 A1
20050203857 Friedman Sep 2005 A1
20050205666 Ward et al. Sep 2005 A1
20050206499 Fisher Sep 2005 A1
20050209917 Anderson et al. Sep 2005 A1
20050216346 Kusumoto et al. Sep 2005 A1
20050216888 Drummond et al. Sep 2005 A1
20050222906 Chen Oct 2005 A1
20050234769 Jain et al. Oct 2005 A1
20050234771 Register et al. Oct 2005 A1
20050234773 Hirst et al. Oct 2005 A1
20050234789 Czyzewski et al. Oct 2005 A1
20050240474 Li Oct 2005 A1
20050240477 Friday et al. Oct 2005 A1
20050242179 Warwick Nov 2005 A1
20050246289 Alexander et al. Nov 2005 A1
20050246627 Sayed Nov 2005 A1
20050251446 Jiang et al. Nov 2005 A1
20050251470 Sullivan Nov 2005 A1
20050251478 Yanavi Nov 2005 A1
20050256794 Colby Nov 2005 A1
20050256802 Ammermann et al. Nov 2005 A1
20050261916 McCall et al. Nov 2005 A1
20050261995 Phelan Nov 2005 A1
20050267800 Tietzen et al. Dec 2005 A1
20050269396 Schofield Dec 2005 A1
20050273386 Weidner Dec 2005 A1
20050273387 Previdi Dec 2005 A1
20050273425 Yamazaki Dec 2005 A1
20050278215 Seele, Jr. Dec 2005 A1
20050283429 Bates et al. Dec 2005 A1
20050288998 Verma et al. Dec 2005 A1
20050289003 Thompson et al. Dec 2005 A1
20050289044 Breslin et al. Dec 2005 A1
20060004629 Neemann et al. Jan 2006 A1
20060010033 Thomas Jan 2006 A1
20060010034 Sparks Jan 2006 A1
20060011719 Lehtonen et al. Jan 2006 A1
20060015463 Gupta et al. Jan 2006 A1
20060020507 Sagey Jan 2006 A1
20060020542 Litle et al. Jan 2006 A1
20060026073 Kenny et al. Feb 2006 A1
20060026092 Klein et al. Feb 2006 A1
20060031718 Thornhill et al. Feb 2006 A1
20060036543 Blagg et al. Feb 2006 A1
20060036553 Gupta et al. Feb 2006 A1
20060039733 Meyerhofer Feb 2006 A1
20060041540 Shannon Feb 2006 A1
20060047573 Mitchell et al. Mar 2006 A1
20060047589 Grau Mar 2006 A1
20060053056 Alspach-Goss et al. Mar 2006 A1
20060064329 Abolfathi et al. Mar 2006 A1
20060074794 Nespola, Jr. Apr 2006 A1
20060080230 Freiberg Apr 2006 A1
20060080243 Kemper et al. Apr 2006 A1
20060080254 Chigira et al. Apr 2006 A1
20060085334 Murphy Apr 2006 A1
20060093123 Becerra et al. May 2006 A1
20060095350 Hall et al. May 2006 A1
20060106696 Carlson May 2006 A1
20060116903 Becerra Jun 2006 A1
20060116995 Strayer et al. Jun 2006 A1
20060122918 Graboske et al. Jun 2006 A1
20060131869 Brignull Jun 2006 A1
20060136231 Thomas Jun 2006 A1
20060143077 Prorock Jun 2006 A1
20060143117 Chigira et al. Jun 2006 A1
20060149671 Nix et al. Jul 2006 A1
20060155628 Horowitz Jul 2006 A1
20060157557 Lee et al. Jul 2006 A1
20060161478 Turner et al. Jul 2006 A1
20060195390 Rusk et al. Aug 2006 A1
20060224480 Bent et al. Oct 2006 A1
20060242057 Velarde Oct 2006 A1
20060249574 Brown et al. Nov 2006 A1
20060251478 Desmeules Nov 2006 A1
20060259364 Strock et al. Nov 2006 A1
20060259390 Rosenberger Nov 2006 A1
20060261927 Kelly et al. Nov 2006 A1
20060289636 Hoblit Dec 2006 A1
20070020443 Lo Jan 2007 A1
20070034700 Poidomani et al. Feb 2007 A1
20070038515 Postrel Feb 2007 A1
20070063025 Blossom Mar 2007 A1
20070078719 Schmitt et al. Apr 2007 A1
20070083461 Andalib et al. Apr 2007 A1
20070118470 Warren et al. May 2007 A1
20070124227 Dembo May 2007 A1
20070136211 Brown et al. Jun 2007 A1
20070156530 Schmitt et al. Jul 2007 A1
20070203825 Hanifin et al. Aug 2007 A1
20070208671 Brown et al. Sep 2007 A1
20070215688 Routhenstein Sep 2007 A1
20070226097 Keechle Sep 2007 A1
20070265924 Schwarz Nov 2007 A1
20080005018 Powell Jan 2008 A1
20080010202 Schwarz Jan 2008 A1
20080019281 Liger et al. Jan 2008 A1
20080027841 Eder Jan 2008 A1
20080133350 White et al. Jun 2008 A1
20080177659 Lacey et al. Jul 2008 A1
20080187770 Funicelli et al. Aug 2008 A1
20080215470 Sengupta et al. Sep 2008 A1
20080230600 Black et al. Sep 2008 A1
20080245865 Mosteller Oct 2008 A1
20080262915 Gojkovic et al. Oct 2008 A1
20080277465 Pletz et al. Nov 2008 A1
20080288396 Siggers et al. Nov 2008 A1
20080301041 Bruk Dec 2008 A1
20090043651 Schwarz Feb 2009 A1
20090048972 Bierer et al. Feb 2009 A1
20090063202 Becerra et al. Mar 2009 A1
20090112639 Beaver Apr 2009 A1
20090132312 Reinheimer et al. May 2009 A1
20090150370 Christensen et al. Jun 2009 A1
20090157437 Becerra et al. Jun 2009 A1
20090171778 Powell Jul 2009 A1
20090230195 Lasch et al. Sep 2009 A1
20090240620 Kendrick et al. Sep 2009 A1
20090242645 Komatsu et al. Oct 2009 A1
20090250522 Williams et al. Oct 2009 A1
20090261161 Blossom Oct 2009 A1
20090265275 Everhart Oct 2009 A1
20090271853 Everhart Oct 2009 A1
20090313106 Taylor et al. Dec 2009 A1
20090313110 Asai et al. Dec 2009 A1
20100030675 Hanan et al. Feb 2010 A1
20100030697 Goodrich et al. Feb 2010 A1
20100057551 Blaisdell Mar 2010 A1
20100057553 Ameiss et al. Mar 2010 A1
20100114779 Noles May 2010 A1
Foreign Referenced Citations (39)
Number Date Country
19702532 Mar 1998 DE
102006015818 Oct 2007 DE
0843292 May 1998 EP
0855659 Jul 1998 EP
0590861 Jan 2001 EP
53-118104 Oct 1978 JP
64-87397 Mar 1989 JP
3-114879 May 1991 JP
4-073193 Mar 1992 JP
4-201392 Jul 1992 JP
5-011676 Jan 1993 JP
8-080680 Mar 1996 JP
8-096098 Apr 1996 JP
10-116016 May 1998 JP
2000-113151 Apr 2000 JP
2002-259933 Sep 2002 JP
2002-366015 Dec 2002 JP
2005-246658 Sep 2005 JP
2008-015071 Jan 2008 JP
9720692 Jun 1997 WO
9810368 Mar 1998 WO
9858345 Dec 1998 WO
9954841 Oct 1999 WO
0111532 Feb 2001 WO
0169347 Sep 2001 WO
0169347 Sep 2001 WO
0169347 Sep 2001 WO
0188659 Nov 2001 WO
2009023817 Feb 2004 WO
2004027564 Apr 2004 WO
2004040419 May 2004 WO
2004114641 Dec 2004 WO
2005101975 Nov 2005 WO
2006060370 Jun 2006 WO
2006105092 Oct 2006 WO
2006116772 Nov 2006 WO
2007115725 Oct 2007 WO
2008021381 Feb 2008 WO
2008021382 Feb 2008 WO
Non-Patent Literature Citations (113)
Entry
U.S. Appl. No. 12/645,927—Non-Final Rejection dated Aug. 5, 2010.
U.S. Appl. No. 12/645,927—Response/Amendment dated Oct. 27, 2010.
U.S. Appl. No. 12/645,927—Final Rejection dated Jan. 4, 2011.
U.S. Appl. No. 12/645,927—Response/Amendment dated Apr. 4, 2011.
U.S. Appl. No. 12/645,927—Non-Final Rejection dated Nov. 9, 2011.
U.S. Appl. No. 12/645,927—Response/Amendment dated Jan. 23, 2012.
U.S. Appl. No. 12/645,927—Final Rejection dated Aug. 2, 2012.
U.S. Appl. No. 13/076,699—Non-Final Rejection dated Oct. 19, 2011.
U.S. Appl. No. 13/076,699—Final Rejection dated Apr. 16, 2012.
U.S. Appl. No. 13/076,699—Non-Final Rejection dated Aug. 15, 2012.
U.S. Appl. No. 13/076,699—Allowed Claims—2012.
Abstract to 2007 JPMorgan Chase Disaster Response Card National Strategy Plan Abstract, Jan. 2007.
Alaska Housing Finance Corporation, Request for Information Banking Services, Quarterly Unaudited Financial Statements, Mar. 31, 2005 (89 pages) JPMC-ACS-00000143-231.
Allen et al., Overview of Smart Cards and the Industry, Smart Cards: Seizing Strategic Business Opportunities, Chapter 1, p. 2-20, Irwin Professional Publishing, 1997.
American Banker, Inc., NCNB to Become Biggest Bank in Visa Debit Card Program, The American Banker, Mar. 8, 1979.
American Bankers Association, The Bank Credit Card Business, 1996.
American Express Incentive Services, Incentive, Sep. 1996, p. 126.
Anonymous, Association of Inventive Gift Certificate Suppliers, Incentive, vol. 169, No. 8, pp. SS1-SS23, Aug. 1995.
Anonymous, Two Chips Can Be Better Than One, May 2001.
Authorization of Financial Agent and Terms of Performance, Debit Card Application for Houston, Texas, Sep. 1991, acs00277412.
Block, First Data Subsidiary Creates Payroll Card for the Bankless, LexisNexis Academic, Credit/Debit/ATMs, p. 10, Mar. 21, 1997.
Board of Governors of the Federal Reserve System—Report to the Congress on the Application of the Electronic Fund Transfer Act to Electronic Stored-Value Products, May 1997, acs00098020.
Bowen, Welfare Agencies Seek Aid From Smart Cards, Card Technology, vol. 7, No. 11 pp. 74-76 (2002).
Business Editors and Real Estate Writers, Business Editors and Real Estate Automotive Writers, Consumers Now Can Know What Loan Rate Offers to Expect Based on Their FICO Credit Score at MyFICO.com, Business Wire, New York, Mar. 6, 2002, p. 1.
Business Wire, Business Wire, Inc., Associates-Corp/AMOCO—Announce Plans to Offer Free Visa and MasterCard Accounts, Business Wire, Aug. 29, 1985.
CardTrak Online, Coca-Cola ATM Money Cards (Apr. 4, 1997) Web page at http://www.cardweb.com/cardtrak/news/cf—4a—97.html printed Apr. 7, 2009 ACS 012.
Cardweb.com, Daily Payment Card News, www.cardweb.com (2004).
Cheney, How Effective Were the Financial Safety Nets in the Aftermath of Katrina, HurricaneKatrinaJan06, Jan. 2006.
Claessens, et al., A Tangled World Wide Web of Security Issues, First Monday, retrieved from the internet at http://www.firstmonday.org/issues/issue7—3/claessens, retrieved from the Internet on Oct. 6, 2006.
D. O'Mahony, Electronic Payment System, 1997, Artech House, XP002137255, p. 7-11.
Davis, Merchants Unbound, Card Technology, Jun. 2004, vol. 9, No. 7, p. 36 (8 pages).
Debit and Stored Value Cards for Government: A Growing Trend but States Could Do More, A Survey and White paper of The EBT Industry Council, Nov. 2006.
Debit Card News—Paperless Trail Leads Debit to a Check-Free Payroll Program, vol. 3, No. 12, Dec. 16, 1997.
Debit Card Services—Invitation for Expressions of Interest, Jul. 1991, acs00277422.
Definition of Store-Value Card, Wikipedia, retrieved from the internet at http://en.wikipedia.org/wiki/Stored-value—card, retrieved from the internet on Apr. 16, 2007.
Direct Payment Card, International EBT Pilot Evaluation Pilot Evaluation—Argentina, Jan. 1996, acs00277456.
Dugas, Payroll May Ask Paper or Plastic?, USA Today, 3B, Aug. 14, 2001, 1 page.
Eight Keys to Making the Right Choice, Incentive, Dec. 1996, 9 pages.
E-Loan, A Better Way to Get a Loan—Frequently Asked Questions (FAQ), Apr. 7, 2001, eloan.com (web.archive.org/web/20010407063242/www.wheels.eloan.com/cgibin/show/autofa . . . ).
E-Loan, A Better Way to Get a Loan, AutoLoan webpage, Apr. 4, 2001, eloan.com (web.archive.org/web20010404223234/www.wheels.eloan.com/cgibin/autoloans?).
E-Loan, Auto Loan Rates (2001).
Exclusively Yours From Maritz . . . The MasterCard Card Ultimate Incentive, Incentive, Oct. 1995, 3 pages.
Feldman, Judy, Pay By Check Over The Phone Or Net, vol. 28, Issue 10, p. 178, Oct. 1, 1999.
FOIA # 09-02-12 Responsive Records Book #11, Mar. 12, 2009, acs00279715.
FOIA # 09-02-12 Responsive Records Book #2, Mar. 12, 2009, acs00277515.
FOIA # 09-02-12 Responsive Records Book #3, Mar. 12, 2009, acs00277531.
FOIA # 09-02-12 Responsive Records Book #5, Mar. 12, 2009, acs00278229.
FOIA # 09-02-12 Responsive Records Book #7, Mar. 12, 2009, acs00278754.
Frequently asked questions, ECARD, www.eregard.com, printed Sep. 23, 2001, 7 pages.
Haddad et al., Congratulations, Grads—You're Bankrupt A Marketing Blitz Buries Kids in Plastic and Debt, Issue 3733, p. 48 (2001).
Hamey, Kenneth, Home Asset Management Accounts Link Mortgages Equity Lines, Oct. 5, 2002.
Hargreaves, The Evaluation of the Expanded EBT Demonstration in Maryland, Final Report, May 1994, acs00092018.
Hight, Jim, Consulting Services, www.strategies-tactics.com, Jan. 24, 1997.
Incentive gift Card: Another way to give the gift of choice!, Incentive, Aug. 1995, 2 pages.
JPMorgan Chase, In Time of Need: A National Strategy for Disaster Response Cards, Treasury Services—Public Sector, Jan. 26, 2007.
Judy Quinn, Incentive Cards Explained, Incentive, Dec. 1995, 5 pages.
Kenneth Hein, What's the Deal?, Incentive, Jul. 1998, 7 pages.
Kibble-Smith, House Committee on Ways and Means, Statement of Brian Kibble-Smith, JPMorgan Chase Treasury Services, Apr. 5, 2006.
Kiley, Branded!, Catalog Age, Jun. 1996, vol. 3, No. 6, p. 77 (4 pages).
Kilian-Kehr, Mobile Security with Smartcards, Dissertation, Apr. 8, 2002.
Kleege, Visa Unveils CoBranding Offensive (Visa International, Visa U.S.A. Inc.), American Banker, v. 159, n. 43, Mar. 4, 1994 (www.dialogclassic.com/MainFrame.jsp, pp. 1-3).
Lennox, Don't Be Tempted By The Urge To Splurge Zero Rates Sound Great But You'll Pay Dearly In The End (2001).
Lewis, Mortgage Lending Optimized, Internet Week, Issue 858, Apr. 23, 2001.
LexisNexis Academic, Debit Card Innovation, vol. XXXV, No. 5, p. 2, May 1997.
LexisNexis Academic, Debit Cards: Payroll Card Ups Fees, Future Banker, p. 18, Oct. 6, 1997.
LexisNexis Academic, NTS' TransPay Debit Card Helps Remote and Unbanked Employees Get Funds Quicker, Financial News, Mar. 18, 1997.
LexisNexis Academic, On the Way, vol. 1997, No. 74, p. 2, Mar. 31, 1997.
Maritz, Incentive, Jun. 1996, p. 111.
McMonagle, Chapter VII—Cash Balance Plans in a Traditional Defined Benefit World, as found on google.scholar (dev.soa.org, Jan. 2002), www.soa.org/.../monographs/retirement-systems/cash-balance-symposium/2002/january/m-rs02-3-07.pdf—May 7, 2009.
Meridian Award Cards, JA8251, Jul. 2000.
Modification # 1 to the Authorization of the Financial Agent and Terms of Performance, Sep. 30, 1993, acs00277482.
Modification # 2 to the Authorization of the Financial Agent and Terms of Performance, Mar. 25, 1994, acs00277490.
Modification # 3 to the Authorization of the Financial Agent and Terms of Performance, Feb. 25, 1995, acs00277500.
Modification # 4 to the Authorization of the Financial Agent and Terms of Performance, Apr. 1, 1996, acs00277507.
National Automated Clearing House Association (NACHA), Business-to-Business EIPP Presentment Models and Payment Options Part One—Presentment Models, Jan. 2001, Counsel for Electronic Billing and Payment, (cebp.nacha.org).
Nilson, The Nilson Report (1998).
American Express and Starwood Launch the New Starwood Preferred Guest (SM) Credit Card from American Express, Jun. 19, 2001, PR Newswire, p. 1.
Smart Cards Forging Into Credit Card Market (1995).
Nora Wood, Corporate Spotlight, Incentive, Dec. 1997, 4 pages.
Nora Wood, The Power of the Card, Incentive, Jul. 1997, 6 pages.
O'Conner, Maritz Gets MasterCard's Stamp of Approval, Business Travel News, Aug. 19, 1996, 2 pages.
Ostroff, Guide to Buying New Cars Used Cars Dealer Scams, Feb. 2, 2001, CarBuyingTips.com.
Paper or Plastic? With these three incentives, The Choice is Yours, Incentive, Feb. 1996, 2 pages.
Plotnick, Bakersfield California Investors Explore Buying Rental Property Apr. 11, 2004.
Power, Loehmann's Compiles Shopper Data Via Credit Card, vol. 28, No. 3, Jan. 7, 1998.
PR Newswire, Delta and American Express Introduce, Always Double Miles Feature on Delta SkyMiles® Cards, Oct. 2, 2000, PR Newswire, p. 1.
Press Release, Mar. 5, 2004, Payment Data Systems Files Patent on Debit Card Payment Solution, American City Business Journals, Inc., Mar. 5, 2004.
Pullar-Strecker, ‘Kiwi card converts unlikely to lead smart revolution; Little support for changes to risk allocation’ (2 Edition) Dominion. Wellington, New Zealand; Apr. 25, 2000, p. IT.6.
Quinn, For Many College Youths, Credit Cards Easy to Get, American Express article; St. Louise Post-Dispatch; Feb. 3, 1989.
Ramsaran, Co-Branded Cards Take Flight, Bank Systems & Technology, May 1, 2005, 52 (1 page).
Request for Information submitted to Department of Health and Human Services by JPMorgan Electronic Financial Services, Request for Information for EBT Services, Aug. 10, 2006.
Roberts, Fnb And Nedcor Launch Into The New Era Of Smart Card Banking Nov. 15, 1998.
Rolfe, Europe's Co-branding Boom, Credit Card Management, Jan. 2003, vol. 15, No. 11, p. 16 (4 pages).
Rossman, Kenneth, Summary Appraisal of Real Property, Feb. 13, 2002.
Sessums, Unbanked Citizens Draw Government Attention, vol. 9, No. 4, (1997) acs00280762.
Sherer, Deals & Deal Makers Web Ventures Seek To Facilitate Business Credit, Private Equity (1999).
Siegel et al., Accounting Handbook, Second Edition, 7 pgs. (1995).
Tah et al., Information Modeling for a Construction Project Risk Management System, Engineering Construction and Architectural Management, 2000, vol. 7, No. 2, pp. 107-119.
The Evolution of a New Consumerism, Chain Store Age, vol. 73, Jun. 1997, pp. 8-9.
The Federal Transit Administration, TCRP Report 32 Multipurpose Transit Payment Media, Chapter 2 Multipurpose Fare Payment: Overview, p. 10-20, 1998.
The State of Arkansas, Arkansas Code of 1987 Annotated (1987).
Thai Smart Card to Expand Abroad (Smart Loyalty's Smart Bonus Program has 300,000 Cardholders in Thailand, the company plans to expand into markets that include Australia and Malaysia), Cards International, n. 183 p. 5, Sep. 22, 1997, (www.d.
Vincent Alonzo, Incentive Marketing . . . Three If By Smart Card, Incentive Sep. 1995, p. 11.
Vivo Tech, ViVOtech, Inc. RF-Based Contactless Payment A more convenient way to pay, White Paper—Version 2.0, Apr. 2004.
Ward, New Debit Card is Introduced to Serve Unbanked Workers, News & Business, Jun. 23, 1999.
Welcome to Card Express CardEx, CardEx website archived by web.archive on Oct. 31, 1996, http://web.archive.org/web/*/http://www.cardex.com, retrieve Oct. 18, 2003, 7 pages.
Welcome to Card Express, The CardEx Incentive Card, as disclosed in the CardEx web site archived by web.archive.org on Feb. 7, 1998, http://web.archive.org/web/*/http://www.cardex.com, retrieve Oct. 18, 2003, 8 pages.
Wells Fargo Blazes New Trail for Homeowners, Oct. 6, 2002.
Wenninger et al., The Electronic Purse, Current Issues in Economics and Finance, vol. 1, No. 1, Apr. 1995, acs00098037.
Wolf, Harold A., Personal Finance (1981).
Wood et al., Electronic Transfer of Government Benefits, Federal Reserve Bulletin, pp. 203-217, Apr. 1997.
Yee, Bennet, Using Secure Coprocessors (1994).
Youll, James, Peer to Peer Transactions in Agent Mediated Electronic Commerce (2001).
Related Publications (1)
Number Date Country
20110184846 A1 Jul 2011 US
Continuations (2)
Number Date Country
Parent 12645927 Dec 2009 US
Child 13082165 US
Parent 11331141 Jan 2006 US
Child 12645927 US